Citius Oncology partners with EVERSANA for LYMPHIR drug launch

Go back to Citius Oncology partners with EVERSANA for LYMPHIR drug launch
(NASDAQ: CTOR) Delayed: 0.56 -0.02 (3.45%)
Previous Close $0.58    52 Week High
Open $0.57    52 Week Low
Day High $0.59    P/E N/A 
Day Low $0.54    EPS
Volume 55,823       

(NASDAQ: CTXR) Delayed: 0.52 -0.01 (1.89%)
Previous Close $0.53    52 Week High $2.50 
Open $0.54    52 Week Low $0.40 
Day High $0.54    P/E N/A 
Day Low $0.50    EPS $0.00 
Volume 176,711